Valproate use in women restricted

Valproate should not be prescribed to female patients unless other treatments are ineffective or not tolerated, the MHRA has advised.

The risk of abnormal pregnancy outcomes with valproate may be increasead when it is taken with other epilepsy medicines.
The risk of abnormal pregnancy outcomes with valproate may be increasead when it is taken with other epilepsy medicines.

New guidance has been issued on the use of valproate in women with epilepsy or bipolar disorder, after a Europe-wide review found that children exposed to the drug in utero are at high risk of serious developmental disorders including autism (in up to 30–40% of cases) and/or congenital malformations (in approximately 10% of cases).

Further information
View valproate drug records
MHRA Drug Safety Update

Female patients (including children, adolescents and women of childbearing potential) should be informed of the risks associated with the use of valproate (including sodium valproate, valproic acid and valproate semisodium) during pregnancy and the need to use effective contraception. Treatment should be regularly reviewed and prescribers should advise women to seek medical advice rapidly if they are planning a pregnancy or become pregnant.

Sodium valproate (eg, Epilim, Episenta) and valproic acid (Convulex, Depakote) are now black triangle medicines and are therefore subject to additional monitoring via the Yellow Card scheme.


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.